Design Therapeutics (DSGN) Revenue (2020)
Design Therapeutics (DSGN) posted quarterly Revenue of $33000.0 for Q4 2020, up 65.0% on a QoQ basis from $20000.0 in Q3 2020.
Powered by 
Analysis
Design Therapeutics (DSGN) Revenue (2020) Analysis & Trends
Design Therapeutics has reported Revenue for 1 years, with the latest figure at $33000.0 in Q4 2020.
- Revenue for Q4 2020 came in at $33000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $226000.0 (changed N/A YoY), and the FY2020 annual result was $226000.0, changed N/A from the prior year.
- Revenue climbed to $33000.0 in Q4 2020, from $20000.0 in the prior quarter.
- Over five years, Revenue peaked at $142000.0 in Q1 2020 and troughed at $20000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Design Therapeutics | 953.52 Mn | 746.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 33,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Mar 31, 2020 | 142,000.00 |